Legal sources with official primary sources

Printed ·

SMLM Previewerrors, bugs and incomplete coverage may occurThe model is production-ready during Q4-26

Skip to main content
Skip to the answer

Back to the act

EU regulatory register · PRODUCT-LIABILITY

Article 4Definitions

CELEX 32024L2853 · Read on 2026-08-22

Share this page

Short answer

For the purposes of this Directive, the following definitions apply:

Verbatim from the article. Source: NovaCopilot · https://legal.exploreworldai.com/eu/rattsakter/produktansvar-2024-2853/artikel-4 · Short answer as data · Official text

Official text

Read from the EU Publications Office for this CELEX number. The wording stands as published; nothing here is rewritten or summarised.

For the purposes of this Directive, the following definitions apply:

(1)

‘product’ means all movables, even if integrated into, or inter-connected with, another movable or an immovable; it includes electricity, digital manufacturing files, raw materials and software;

(2)

‘digital manufacturing file’ means a digital version of, or digital template for, a movable which contains the functional information necessary to produce a tangible item by enabling the automated control of machinery or tools;

(3)

‘related service’ means a digital service that is integrated into, or inter-connected with, a product in such a way that its absence would prevent the product from performing one or more of its functions;

(4)

‘component’ means any item, whether tangible or intangible, raw material or related service, that is integrated into, or inter-connected with, a product;

(5)

‘manufacturer’s control’ means that:

(a)

the manufacturer of a product performs or, with regard to actions of a third party, authorises or consents to:

(i)

The article continues in the official text.

Open the article on EUR-Lex

Follow-up questions

Judgments of the Court of Justice

1 decisions

  • C-621/15Court of Justice of the European Union

    N. W and Others v Sanofi Pasteur MSD SNC and Others

    Reference for a preliminary ruling — Directive 85/374/EEC — Liability for defective products — Article 4 — Pharmaceutical laboratories — Vaccination against hepatitis B — Multiple sclerosis — Proof of defect of vaccine and of causal link between the defect and the damage suffered — Burden of proof — Methods of proof — Lack of scientific consensus — Serious, specific and consistent evidence left to the discretion of the court ruling on the merits — Whether permissible — Conditions.

    Ask NovaCopilot

The text is quoted from the official source and is not legal advice. A national court reads the language version that binds in its jurisdiction.

Verifiable trust signals

  • Source-linked answers and explicit evidence gaps
  • Obligations, controls, risks and consequences
  • Stable objects and verifiable checksums
  • Rule-based objects, optional source-linked reasoning
  • Model card, source status and audit

Model cardAudit